BIBDX
Price
$11.88
Change
+$0.10 (+0.85%)
Updated
Jul 31 closing price
Net Assets
829.24M
LVAGX
Price
$21.44
Change
+$0.01 (+0.05%)
Updated
Jul 31 closing price
Net Assets
113.86M
Interact to see
Advertisement

BIBDX vs LVAGX

BIBDX vs LVAGX Comparison Chart in %
View a ticker or compare two or three
VS
BIBDX vs. LVAGX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIBDX is a Hold and LVAGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BIBDX has more cash in the bank: 829M vs. LVAGX (114M). LVAGX pays higher dividends than BIBDX: LVAGX (1.88) vs BIBDX (1.25). BIBDX was incepted earlier than LVAGX: BIBDX (18 years) vs LVAGX (12 years). LVAGX (1.26) is less costly to investors than BIBDX (0.80). BIBDX is a more actively managed with annual turnover of: 44.00 vs. LVAGX (15.00). LVAGX has a lower initial minimum investment than BIBDX: LVAGX (1000) vs BIBDX (2000000). LVAGX annual gain was more profitable for investors over the last year : 36.63 vs. BIBDX (-3.92). LVAGX return over 5 years is better than : 76.93 vs. BIBDX (2.74).
BIBDXLVAGXBIBDX / LVAGX
Total Expense Ratio0.801.1570%
Annual Report Gross Expense Ratio0.801.2663%
Fund Existence18 years12 years-
Gain YTD1.21824.7245%
Front LoadN/AN/A-
Min. Initial Investment20000001000200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets829M114M727%
Annual Yield % from dividends1.251.8866%
Returns for 1 year-3.9236.63-11%
Returns for 3 years8.3970.1912%
Returns for 5 years2.7476.934%
Returns for 10 years17.46172.8210%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JFARX37.150.57
+1.56%
JHancock Fundamental All Cap Core R4
MEIIX55.400.28
+0.51%
MFS Value I
AASSX26.910.08
+0.30%
American Beacon Small Cp Val Adv
TQTIX19.54-0.17
-0.86%
AMG TimesSquare International SmallCap I
GGHSX41.86-0.68
-1.60%
Invesco Health Care R6